Download Now: Exclusive Guide About India's Potentially Decade-Long $10 Trillion Bull Run...
Here is the latest financial fact sheet of ALEMBIC. For more details, see the ALEMBIC quarterly results and ALEMBIC share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | -0.7 |
No. of shares | m | 256.78 |
1 Week | % | 3.2 |
1 Month | % | 16.6 |
1 Year | % | 56.6 |
52 week H/L | Rs | 107.5/59.9 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
ALEMBIC EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 62 | 65 | 123 | 143 | 87 | |
Low | Rs | 36 | 25 | 32 | 72 | 56 | |
Sales per share (Unadj.) | Rs | 4.8 | 2.9 | 2.9 | 3.0 | 5.0 | |
Earnings per share (Unadj.) | Rs | 1.6 | 3.6 | 0.5 | 3.4 | 3.1 | |
Diluted earnings per share | Rs | 1.6 | 3.6 | 0.5 | 3.4 | 3.1 | |
Cash flow per share (Unadj.) | Rs | 1.7 | 3.7 | 0.7 | 3.5 | 3.4 | |
Dividends per share (Unadj.) | Rs | 0.20 | 0.60 | 0.20 | 1.80 | 2.20 | |
Adj. dividends per share | Rs | 0.20 | 0.60 | 0.20 | 1.80 | 2.20 | |
Avg Dividend yield | % | 0.4 | 1.3 | 0.3 | 1.7 | 3.1 | |
Book value per share (Unadj.) | Rs | 47.1 | 55.2 | 89.5 | 97.2 | 80.9 | |
Adj. book value per share | Rs | 47.1 | 55.2 | 89.5 | 97.2 | 80.9 | |
Shares outstanding (eoy) | m | 256.78 | 256.78 | 256.78 | 256.78 | 256.78 | |
Price / Sales ratio | x | 10.2 | 15.6 | 27.0 | 35.3 | 14.4 | |
Avg P/E ratio | x | 30.7 | 12.4 | 143.5 | 32.1 | 22.7 | |
P/CF ratio (eoy) | x | 28.8 | 12.0 | 111.7 | 30.4 | 21.0 | |
Price / Book Value ratio | x | 1.0 | 0.8 | 0.9 | 1.1 | 0.9 | |
Dividend payout | % | 12.5 | 16.6 | 37.1 | 53.6 | 70.1 | |
Avg Mkt Cap | Rs m | 12,608 | 11,523 | 19,868 | 27,643 | 18,298 | |
Total wages/salary | Rs m | 205 | 208 | 226 | 215 | 240 |
ALEMBIC INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 1,238 | 739 | 735 | 782 | 1,272 | |
Other income | Rs m | 302 | 935 | 109 | 892 | 643 | |
Total revenues | Rs m | 1,540 | 1,675 | 844 | 1,674 | 1,915 | |
Gross profit | Rs m | 174 | 31 | 104 | 139 | 297 | |
Depreciation | Rs m | 26 | 32 | 39 | 49 | 67 | |
Interest | Rs m | 2 | 3 | 4 | 4 | 5 | |
Profit before tax | Rs m | 447 | 932 | 170 | 979 | 868 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 36 | 1 | 32 | 117 | 62 | |
Profit after tax | Rs m | 411 | 930 | 138 | 862 | 806 | |
Gross profit margin | % | 14.0 | 4.2 | 14.2 | 17.8 | 23.4 | |
Effective tax rate | % | 8.0 | 0.1 | 18.8 | 11.9 | 7.1 | |
Net profit margin | % | 33.2 | 125.8 | 18.8 | 110.2 | 63.4 |
ALEMBIC BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 987 | 1,628 | 1,021 | 1,433 | 1,721 | |
Current liabilities | Rs m | 488 | 458 | 594 | 678 | 838 | |
Net working cap to sales | % | 40.3 | 158.3 | 58.1 | 96.6 | 69.4 | |
Current ratio | x | 2.0 | 3.6 | 1.7 | 2.1 | 2.1 | |
Inventory Days | Days | 2,952 | 5,596 | 10,191 | 10,346 | 5,038 | |
Debtors Days | Days | 398 | 444 | 686 | 710 | 673 | |
Net fixed assets | Rs m | 11,671 | 13,079 | 23,069 | 24,886 | 20,324 | |
Share capital | Rs m | 514 | 514 | 514 | 514 | 514 | |
"Free" reserves | Rs m | 11,572 | 13,667 | 22,457 | 24,452 | 20,267 | |
Net worth | Rs m | 12,085 | 14,180 | 22,970 | 24,966 | 20,780 | |
Long term debt | Rs m | 0 | 0 | 0 | 0 | 0 | |
Total assets | Rs m | 12,658 | 14,707 | 24,090 | 26,320 | 22,046 | |
Interest coverage | x | 207.8 | 324.5 | 48.1 | 252.6 | 187.7 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 0.1 | 0.1 | 0 | 0 | 0.1 | |
Return on assets | % | 3.3 | 6.3 | 0.6 | 3.3 | 3.7 | |
Return on equity | % | 3.4 | 6.6 | 0.6 | 3.5 | 3.9 | |
Return on capital | % | 3.7 | 6.6 | 0.8 | 3.9 | 4.2 | |
Exports to sales | % | 2.5 | 2.2 | 1.5 | 2.0 | 1.2 | |
Imports to sales | % | 31.2 | 18.6 | 6.1 | 0.3 | 2.4 | |
Exports (fob) | Rs m | 30 | 16 | 11 | 16 | 16 | |
Imports (cif) | Rs m | 386 | 138 | 45 | 2 | 30 | |
Fx inflow | Rs m | 30 | 16 | 11 | 16 | 16 | |
Fx outflow | Rs m | 387 | 138 | 45 | 2 | 30 | |
Net fx | Rs m | -357 | -121 | -34 | 13 | -14 |
ALEMBIC CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 215 | 65 | -22 | -177 | 389 | |
From Investments | Rs m | 717 | 567 | -349 | 188 | 73 | |
From Financial Activity | Rs m | -920 | -64 | -154 | -58 | -464 | |
Net Cashflow | Rs m | 12 | 569 | -524 | -47 | -2 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Chirayu Amin | COMP SEC: Drigesh Mittal | YEAR OF INC: 1907 | BSE CODE: 506235 | FV (Rs): 2 | DIV YIELD (%): 2.3 |
Read: ALEMBIC 2022-23 Annual Report Analysis
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare ALEMBIC With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.